InvestorsHub Logo
Followers 4
Posts 84
Boards Moderated 0
Alias Born 07/02/2016

Re: pearsby09 post# 11172

Tuesday, 02/21/2017 3:07:00 PM

Tuesday, February 21, 2017 3:07:00 PM

Post# of 233559
They bought the priority review voucher, not the drug. The FDA allows these vouchers to be sold on the open market as an incentive for companies to develop 'less-lucrative' drugs. Gilead can apply the PRV to a drug of their choosing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News